コレステロール検査市場：製品タイプ、検査項目、処方形態、エンドユーザー別-2025-2030年世界予測

コレステロール検査市場は、2023年に189億7,000万米ドルと評価され、2024年には207億2,000万米ドルに達すると予測され、CAGR 9.71％で成長し、2030年には363億1,000万米ドルに達すると予測されています。

コレステロール検査は、予防ヘルスケア分野において重要なコンポーネントであり、心血管疾患のリスクを評価する診断ツールとして機能します。この市場の範囲は、医療施設、診断センター、家庭用検査キットなどの用途によって定義されます。コレステロール検査の必要性は、高脂血症や肥満などのライフスタイルに関連した疾患の有病率の増加によって強調され、定期的なスクリーニングの需要を促進しています。最終用途分野には病院、診療所、研究所などがあり、いずれも公衆衛生管理における広範なデータ収集と分析に貢献しています。市場の成長は、検査機器の技術的進歩、一般市民の意識の高まり、定期的な健康診断を推進する政府の取り組みに影響を受けています。個別化医療やデジタルヘルス技術の台頭は、特に遠隔モニタリングや検査を可能にするAI主導の診断ツールやモバイルヘルスアプリの統合を通じて新たな機会をもたらし、市場のアクセシビリティを拡大します。しかし、高度な検査ソリューションの高コスト、厳格な規制基準、患者データに関連するプライバシーの懸念などにより、市場の成長は限界に直面しています。さらに、経済格差が発展途上地域における継続的検査へのアクセスを制限する可能性もあります。企業にとって有望な技術革新分野には、非侵襲的で費用対効果の高い検査法の開発や、手頃なソリューションを消費者に直接提供するポイントオブケア検査機器などがあります。バイオマーカーの発見や、リアルタイムの健康モニタリングのためのIoTデバイスの統合に調査の機会があります。市場情勢は競合情勢を特徴としており、多くの企業がイノベーションを通じて差別化された製品を提供しようと努力しています。成功するためには、企業は規制上の課題に対処し、消費者教育に投資し、検査への公平なアクセスを確保する必要があります。テクノロジー・プロバイダーとの戦略的提携により、サービスの質と市場へのリーチをさらに高めることができ、在宅医療や予防医療ソリューションへのバランスの変化を活用することができます。

市場力学：急速に進化するコレステロール検査市場の主要市場インサイトを公開

コレステロール検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患の蔓延
  • 食習慣の変化に起因する肥満人口の急増
  • 世界の老人人口の急増
• 市場抑制要因
  • 非侵襲的コレステロール検査の利用可能性と自己検査に対する嗜好性
• 市場機会
  • 定期的なコレステロール検査を受けるための政府および民間団体による好意的なキャンペーン
  • ヘルスケアへの旺盛な投資と技術進歩
• 市場の課題
  • 検査における厳しい規制政策

ポーターの5つの力：コレステロール検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コレステロール検査市場における外部からの影響の把握

外部マクロ環境要因は、コレステロール検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コレステロール検査市場における競合情勢の把握

コレステロール検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコレステロール検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コレステロール検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コレステロール検査市場における成功への道筋を描く

コレステロール検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が増加
    • 肥満者の増加は食習慣の変化によるも
    • 世界中で高齢者人口が急増
  • 抑制要因
    • 自己検査の可用性と好み、および非侵襲性コレステロール検査の好み
  • 機会
    • 政府と民間団体がコレステロール定期検査の受診を推奨
    • ヘルスケアと技術の進歩への強力な投資
  • 課題
    • テストにおける厳格な規制方針
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コレステロール検査市場：製品タイプ別

• 検査キット
• 検査ストリップ

第7章 コレステロール検査市場テスト別

• 高密度リポタンパク質
• 低密度リポタンパク質
• 総コレステロール検査

第8章 コレステロール検査市場テストタイプ別

• 侵襲的
• 非侵襲的

第9章 コレステロール検査市場処方箋モード

• 店頭
• 処方箋に基づく

第10章 コレステロール検査市場：エンドユーザー別

• 外来センター
• クリニック
• 診断センター
• ホームケア
• 病院

第11章 南北アメリカのコレステロール検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のコレステロール検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのコレステロール検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ACM Global Laboratories
• Apollo Clinics
• BioReference Health, LLC
• Cell Biolabs, Inc.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Quest Diagnostics Incorporated
• Randox Laboratories Ltd.
• SEKISUI Diagnostics
• Siemens Healthineers AG
• SpectraCell Laboratories, Inc.
• SYNLAB International GmbH
• Thermo Fisher Scientific Inc.
• Unilab Clinical Laboratory

LIST OF FIGURES

• FIGURE 1. CHOLESTEROL TESTING MARKET RESEARCH PROCESS
• FIGURE 2. CHOLESTEROL TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CHOLESTEROL TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CHOLESTEROL TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HIGH-DENSITY LIPOPROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY LOW-DENSITY LIPOPROTEIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TOTAL CHOLESTEROL TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CHOLESTEROL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 235. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Cholesterol Testing Market was valued at USD 18.97 billion in 2023, expected to reach USD 20.72 billion in 2024, and is projected to grow at a CAGR of 9.71%, to USD 36.31 billion by 2030.

Cholesterol testing is a critical component in the field of preventive healthcare, serving as a diagnostic tool to assess the risk of cardiovascular diseases. This market's scope is defined by its applications across medical facilities, diagnostic centers, and home testing kits. The necessity of cholesterol testing is underscored by the increasing prevalence of lifestyle-related conditions such as hyperlipidemia and obesity, driving demand for regular screening. End-use sectors include hospitals, clinics, and research laboratories, all of which contribute to extensive data collection and analysis in public health management. Market growth is influenced by technological advancements in testing equipment, heightened public awareness, and government initiatives promoting regular health check-ups. The rise of personalized medicine and digital health technologies presents new opportunities, specifically through the integration of AI-driven diagnostic tools and mobile health apps that enable remote monitoring and testing, thus expanding market accessibility. However, market growth faces limitations due to high costs of advanced testing solutions, stringent regulatory standards, and privacy concerns related to patient data. Additionally, economic disparities may limit access to continuous testing in developing regions. For businesses, promising areas of innovation include the development of non-invasive and cost-effective testing methods, as well as point-of-care testing devices that bring affordable solutions directly to consumers. Research opportunities lie in biomarker discovery and integration of IoT devices for real-time health monitoring. The cholesterol testing market is characterized by a competitive landscape with numerous players striving to offer differentiated products through innovation. Successful navigation requires companies to address regulatory challenges, invest in consumer education, and ensure equitable access to testing. Strategic collaborations with technology providers can further enhance service quality and market reach, positioning firms to capitalize on the shifting balance toward home-based and preventive healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cholesterol Testing Market

The Cholesterol Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cardiovascular diseases worldwide
  • Proliferation in number of obese people attributed to changing eating habits
  • Surge in the geriatric population across the globe
• Market Restraints
  • Availability and preference over self-testing and preference for non-invasive cholesterol tests
• Market Opportunities
  • Favorable government and private organization campaigns to undergo regular cholesterol checkups
  • Robust investment in healthcare and technological advancements
• Market Challenges
  • Strict regulatory policies in testing

Porter's Five Forces: A Strategic Tool for Navigating the Cholesterol Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cholesterol Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cholesterol Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cholesterol Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cholesterol Testing Market

A detailed market share analysis in the Cholesterol Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cholesterol Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cholesterol Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cholesterol Testing Market

A strategic analysis of the Cholesterol Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cholesterol Testing Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Apollo Clinics, BioReference Health, LLC, Cell Biolabs, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SEKISUI Diagnostics, Siemens Healthineers AG, SpectraCell Laboratories, Inc., SYNLAB International GmbH, Thermo Fisher Scientific Inc., and Unilab Clinical Laboratory.

Market Segmentation & Coverage

This research report categorizes the Cholesterol Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Test Kits and Testing Strips.
• Based on Test, market is studied across High-Density Lipoprotein, Low-Density Lipoprotein, and Total Cholesterol Test.
• Based on Test Type, market is studied across Invasive and Non-Invasive.
• Based on Prescription Mode, market is studied across Over the Counter and Prescription-Based.
• Based on End-Users, market is studied across Ambulatory Centers, Clinics, Diagnostic Centers, Homecare, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cardiovascular diseases worldwide
    • 5.1.1.2. Proliferation in number of obese people attributed to changing eating habits
    • 5.1.1.3. Surge in the geriatric population across the globe
  • 5.1.2. Restraints
    • 5.1.2.1. Availability and preference over self-testing and preference for non-invasive cholesterol tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable government and private organization campaigns to undergo regular cholesterol checkups
    • 5.1.3.2. Robust investment in healthcare and technological advancements
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory policies in testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cholesterol Testing Market, by Product Type

• 6.1. Introduction
• 6.2. Test Kits
• 6.3. Testing Strips

7. Cholesterol Testing Market, by Test

• 7.1. Introduction
• 7.2. High-Density Lipoprotein
• 7.3. Low-Density Lipoprotein
• 7.4. Total Cholesterol Test

8. Cholesterol Testing Market, by Test Type

• 8.1. Introduction
• 8.2. Invasive
• 8.3. Non-Invasive

9. Cholesterol Testing Market, by Prescription Mode

• 9.1. Introduction
• 9.2. Over the Counter
• 9.3. Prescription-Based

10. Cholesterol Testing Market, by End-Users

• 10.1. Introduction
• 10.2. Ambulatory Centers
• 10.3. Clinics
• 10.4. Diagnostic Centers
• 10.5. Homecare
• 10.6. Hospitals

11. Americas Cholesterol Testing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cholesterol Testing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cholesterol Testing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACM Global Laboratories
• 2. Apollo Clinics
• 3. BioReference Health, LLC
• 4. Cell Biolabs, Inc.
• 5. Eurofins Scientific SE
• 6. F. Hoffmann-La Roche Ltd.
• 7. Merck KGaA
• 8. Quest Diagnostics Incorporated
• 9. Randox Laboratories Ltd.
• 10. SEKISUI Diagnostics
• 11. Siemens Healthineers AG
• 12. SpectraCell Laboratories, Inc.
• 13. SYNLAB International GmbH
• 14. Thermo Fisher Scientific Inc.
• 15. Unilab Clinical Laboratory